Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Matti Ahlqvist"'
Autor:
Ralf Degenhardt, Matti Ahlqvist, Lars S. Maier, Magnus Jörntén-Karlsson, Jürgen vom Dahl, Alexander Ghanem, Till Köhler, Florian Krackhardt, Matthias W. Waliszewski, Carsten Tschoepe, Karl‐Friedrich Appel, Anna Niklasson
Publikováno v:
Clinical Cardiology
A novel smartphone‐based patient support tool was developed to increase the adherence to antiplatelet therapy and lifestyle changes in patients after coronary angioplasty for acute coronary syndrome (ACS). The eMocial study (http://clinicaltrials.g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d89128d1262a2a85e3b91add0370e75
http://europepmc.org/articles/PMC6837026
http://europepmc.org/articles/PMC6837026
Publikováno v:
European Journal of Pharmaceutical Sciences. 104:262-272
A compound, which is a selective peroxisome proliferator activated receptor (PPAR) agonist, was investigated. The aim of the presented studies was to evaluate the potential of the further development of the compound. Fundamental physicochemical prope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a410a389535d15dac7fb743aa89d41
https://doi.org/10.1016/j.ejps.2017.03.041
https://doi.org/10.1016/j.ejps.2017.03.041
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 120
The purpose of this study was to investigate if AZD5329, a dual neurokinin NK1/2 receptor antagonist, is a suitable candidate for further development as an oral immediate release (IR) solid dosage form as a final product. The neutral form of AZD5329
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0156fded234003d5605e26f0b16919f6
https://pubmed.ncbi.nlm.nih.gov/29730322
https://pubmed.ncbi.nlm.nih.gov/29730322
Publikováno v:
Drug Development and Industrial Pharmacy. 37:702-713
The purpose of the present study was to find out if AZD8081, a dual neurokinin (NK)1/2 receptor antagonist, was suitable for development of an oral, solid immediate release (IR) formulation and in a further perspective also as an oral extended releas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1716da6729d79af9d19dabe95f5cc3ae
https://doi.org/10.3109/03639045.2010.535823
https://doi.org/10.3109/03639045.2010.535823
Autor:
Matti Ahlqvist, Lynne S. Taylor
Publikováno v:
Journal of Pharmaceutical Sciences. 91:690-698
Water interacts with pharmaceutical materials in a number of different ways. The aim of this study was to investigate if exchange experiments with D(2)O can provide useful insights into the structure of hydrated materials. Raffinose pentahydrate, tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09de6a93673cd3906f96840fd01abd7a
https://doi.org/10.1002/jps.10068
https://doi.org/10.1002/jps.10068
Publikováno v:
Drug development and industrial pharmacy. 37(6)
The purpose of this study was to investigate whether AZD2738, a dual neurokinin NK1/2 receptor antagonist, is a suitable candidate for further development with an oral immediate release solid dosage form as a possible final product. The neutral form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247b669b970aa72c6a00117d83a2cd0a
https://pubmed.ncbi.nlm.nih.gov/21323487
https://pubmed.ncbi.nlm.nih.gov/21323487
Autor:
Matti Ahlqvist, Lynne S. Taylor
Publikováno v:
International journal of pharmaceutics. 241(2)
The dynamics and interactions of water with different channel hydrates were studied. Caffeine 4/5-hydrate, theophylline monohydrate and sodium cromoglycate were used as model compounds. The hydrogen/deuterium (H/D) exchange of the different hydrates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0547be8fd900e267e59ad2d731b3654
https://pubmed.ncbi.nlm.nih.gov/12100853
https://pubmed.ncbi.nlm.nih.gov/12100853